Skip to main content
Top
Published in: International Urology and Nephrology 6/2020

01-06-2020 | Kidney Transplantation | Nephrology - Original Paper

The impact of donor urine chemical toxicology analysis on outcomes of kidney transplantation

Authors: Karim M. Soliman, Christopher Molini, Tessa Novick, Steven Menez, Tibor Fülöp, Edward Kraus, Blaithin A. McMahon

Published in: International Urology and Nephrology | Issue 6/2020

Login to get access

Abstract

Background

Acceptance of organs from acute chemical intoxicated donors remains controversial and outcomes are insufficiently explored.

Methods

This is a single-center retrospective cohort analysis of 484 patients undergoing deceased donor kidney transplantation (DDKT). We assessed the association of positive urine drug screen before transplantation with cohort statistics, delayed graft function (DGF), and graft outcomes at 2 years. Multiple logistical regression (MLR) analysis was used to assess the odds ratio for DGF.

Results

Of 484 random DDKTs performed at our institution between January 2010 and October 2015, 280 deceased kidney donors were current drug users. Mean age was 35.4 (15) years, 39% male, 61% were African Americans, and 38.2% had more than one test positive. The main chemical toxins detectable in donor urine were alcohol, heroin, opioid/methadone, cocaine, marijuana, benzodiazepines, methamphetamine, ecstasy, and LSD. Single and multiple urine chemical toxicology of kidney donors did not have a significant effect on KT outcomes of DGF and graft failure during a median follow-up (P for odds ratios > 0.05).

Conclusions

The use of deceased donor kidney grafts from donors with positive urine chemical toxicology may be a worthwhile method of increasing the availability of scarce donor kidney organs as such exposure to illicit drug(s) is not associated with major adverse transplant outcomes.
Literature
1.
go back to reference Matas AJ, Smith JM, Skeans MA et al (2014) OPTN/SRTR 2012 annual data report: kidney. Am J Transpl 14(Suppl 1):11–44CrossRef Matas AJ, Smith JM, Skeans MA et al (2014) OPTN/SRTR 2012 annual data report: kidney. Am J Transpl 14(Suppl 1):11–44CrossRef
2.
go back to reference Durand CM, Bowring MG, Thomas AG et al (2018) The drug overdose epidemic and deceased-donor transplantation in the United States: a national registry study. Ann Intern Med 168(10):702–711CrossRef Durand CM, Bowring MG, Thomas AG et al (2018) The drug overdose epidemic and deceased-donor transplantation in the United States: a national registry study. Ann Intern Med 168(10):702–711CrossRef
3.
go back to reference Vaduganathan M, Machado SR, DeFilippis EM et al (2019) Organ donation and drug intoxication-related deaths in the United States. N Engl J Med 380(6):597–599CrossRef Vaduganathan M, Machado SR, DeFilippis EM et al (2019) Organ donation and drug intoxication-related deaths in the United States. N Engl J Med 380(6):597–599CrossRef
4.
go back to reference Chute DF, Sise ME (2018) Effect of the opioid crisis on the donor pool for kidney transplantation: an analysis of national kidney deceased donor trends from 2010–2016. Am J Nephrol 47(2):84–93CrossRef Chute DF, Sise ME (2018) Effect of the opioid crisis on the donor pool for kidney transplantation: an analysis of national kidney deceased donor trends from 2010–2016. Am J Nephrol 47(2):84–93CrossRef
5.
go back to reference Chan YH (2003) Biostatistics 102: quantitative data–parametric & non-parametric tests. Singapore Med J 44(8):391–396PubMed Chan YH (2003) Biostatistics 102: quantitative data–parametric & non-parametric tests. Singapore Med J 44(8):391–396PubMed
6.
go back to reference Chan YH (2003) Biostatistics 103: qualitative data—tests of independence. Singapore Med J 44(10):498–503PubMed Chan YH (2003) Biostatistics 103: qualitative data—tests of independence. Singapore Med J 44(10):498–503PubMed
7.
go back to reference Wood DM, Dargan PI, Jones AL (2003) Poisoned patients as potential organ donors: postal survey of transplant centres and intensive care units. Crit Care (Lond Engl) 7(2):147–154CrossRef Wood DM, Dargan PI, Jones AL (2003) Poisoned patients as potential organ donors: postal survey of transplant centres and intensive care units. Crit Care (Lond Engl) 7(2):147–154CrossRef
8.
go back to reference Wood DM, Chan WL, Dargan PI (2014) Using drug-intoxicated deaths as potential organ donors: impression of attendees at the American college of medical toxicology 2014 annual scientific meeting. J Toxicol 10(4):360–363CrossRef Wood DM, Chan WL, Dargan PI (2014) Using drug-intoxicated deaths as potential organ donors: impression of attendees at the American college of medical toxicology 2014 annual scientific meeting. J Toxicol 10(4):360–363CrossRef
9.
go back to reference Cho YW, Terasaki PI, Cecka JM. New variables reported to the UNOS registry and their impact on cadaveric renal transplant outcomes—a preliminary study. Clin Transpl 1995:405–415. Cho YW, Terasaki PI, Cecka JM. New variables reported to the UNOS registry and their impact on cadaveric renal transplant outcomes—a preliminary study. Clin Transpl 1995:405–415.
10.
go back to reference Cho YW. Expanded criteria donors. Clin Transpl 1998:421–436. Cho YW. Expanded criteria donors. Clin Transpl 1998:421–436.
11.
go back to reference Leikin JB, Heyn-Lamb R, Aks S, Erickson T, Snyder J (1994) The toxic patient as a potential organ donor. Am J Emerg Med 12(2):151–154CrossRef Leikin JB, Heyn-Lamb R, Aks S, Erickson T, Snyder J (1994) The toxic patient as a potential organ donor. Am J Emerg Med 12(2):151–154CrossRef
12.
go back to reference Tenore PL (2010) Advanced urine toxicology testing. J Addict Dis 29(4):436–448CrossRef Tenore PL (2010) Advanced urine toxicology testing. J Addict Dis 29(4):436–448CrossRef
13.
go back to reference Koerner MM, Tenderich G, Minami K et al (1997) Extended donor criteria: use of cardiac allografts after carbon monoxide poisoning. Transplantation 63(9):1358–1360CrossRef Koerner MM, Tenderich G, Minami K et al (1997) Extended donor criteria: use of cardiac allografts after carbon monoxide poisoning. Transplantation 63(9):1358–1360CrossRef
14.
go back to reference Hebert MJ, Boucher A, Beaucage G, Girard R, Dandavino R (1992) Transplantation of kidneys from a donor with carbon monoxide poisoning. N Engl J Med 326(23):1571PubMed Hebert MJ, Boucher A, Beaucage G, Girard R, Dandavino R (1992) Transplantation of kidneys from a donor with carbon monoxide poisoning. N Engl J Med 326(23):1571PubMed
15.
go back to reference Bentley MJ, Mullen JC, Lopushinsky SR, Modry DL (2001) Successful cardiac transplantation with methanol or carbon monoxide-poisoned donors. Ann Thorac Surg 71(4):1194–1197CrossRef Bentley MJ, Mullen JC, Lopushinsky SR, Modry DL (2001) Successful cardiac transplantation with methanol or carbon monoxide-poisoned donors. Ann Thorac Surg 71(4):1194–1197CrossRef
16.
go back to reference Lopez-Navidad A, Caballero F, Gonzalez-Segura C, Cabrer C, Frutos MA (2002) Short- and long-term success of organs transplanted from acute methanol poisoned donors. Clin Transplant 16(3):151–162CrossRef Lopez-Navidad A, Caballero F, Gonzalez-Segura C, Cabrer C, Frutos MA (2002) Short- and long-term success of organs transplanted from acute methanol poisoned donors. Clin Transplant 16(3):151–162CrossRef
17.
go back to reference Mojtabaee M, Shahryari S, Nikeghbalian S, Shadnia S, Sadegh BF (2017) Liver procurement from poisoned donors, a survival study. Transplantation 101:S91–S92CrossRef Mojtabaee M, Shahryari S, Nikeghbalian S, Shadnia S, Sadegh BF (2017) Liver procurement from poisoned donors, a survival study. Transplantation 101:S91–S92CrossRef
18.
go back to reference Mistry U, Dargan PI, Wood DM (2018) Pesticide-poisoned patients: can they be used as potential organ donors? J Med Toxicol 14(4):278–282CrossRef Mistry U, Dargan PI, Wood DM (2018) Pesticide-poisoned patients: can they be used as potential organ donors? J Med Toxicol 14(4):278–282CrossRef
19.
go back to reference Rodrigus IE, Conraads V, Amsel BJ, Moulijn AC (2001) Primary cardiac allograft failure after donor carbon monoxide poisoning treated with biventricular assist device. J Heart Lung Transpl 20(12):1345–1348CrossRef Rodrigus IE, Conraads V, Amsel BJ, Moulijn AC (2001) Primary cardiac allograft failure after donor carbon monoxide poisoning treated with biventricular assist device. J Heart Lung Transpl 20(12):1345–1348CrossRef
20.
go back to reference Hantson P, Mahieu P, Hassoun A, Otte JB (1995) Outcome following organ removal from poisoned donors in brain death status: a report of 12 cases and review of the literature. J Toxicol Clin Toxicol 33(6):709–712CrossRef Hantson P, Mahieu P, Hassoun A, Otte JB (1995) Outcome following organ removal from poisoned donors in brain death status: a report of 12 cases and review of the literature. J Toxicol Clin Toxicol 33(6):709–712CrossRef
21.
go back to reference Luckraz H, Tsui SS, Parameshwar J, Wallwork J, Large SR (2001) Improved outcome with organs from carbon monoxide poisoned donors for intrathoracic transplantation. Ann Thorac Surg 72(3):709–713CrossRef Luckraz H, Tsui SS, Parameshwar J, Wallwork J, Large SR (2001) Improved outcome with organs from carbon monoxide poisoned donors for intrathoracic transplantation. Ann Thorac Surg 72(3):709–713CrossRef
Metadata
Title
The impact of donor urine chemical toxicology analysis on outcomes of kidney transplantation
Authors
Karim M. Soliman
Christopher Molini
Tessa Novick
Steven Menez
Tibor Fülöp
Edward Kraus
Blaithin A. McMahon
Publication date
01-06-2020
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 6/2020
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-020-02450-w

Other articles of this Issue 6/2020

International Urology and Nephrology 6/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.